News

NPS

0.135

+0.000 (+0.0%)
Language:

(吉隆坡26日讯)诺华医药(NPS,03006,LEAP市场医疗保健组)被全面收购的行动宣告完成,将于3月31日除牌。此前,聚宝建设(SSB8,0045,创业板科技组)全面收购诺华医药,由于已经取得超过90%股权,因此诺华医药被撤除在LEAP市场的上市地位。聚宝建设是在去年12月22日以每股37仙价格,或总价1819万4380万令吉,收购诺华医药大股东、首席执行员兼执行董事邱茂伟(译音)持有的4917万4000股或33.001%股权,触及全面献购门槛,因此建议以每股37仙强制收购未持有剩余股...
Sinchew26 Mar, 2026 20:44pm - 1 month

(吉隆坡26日讯)亚洲股市今日收盘几乎全数收低,而马股随大市下滑。富时综合指数闭市报1710.89点,下跌5.79点或0...
Orientaldaily26 Mar, 2026 18:16pm - 1 month

(吉隆坡13日讯)最新报告指出,国人对国内银行业者的整体服务满意度高达87%;这当中,获得最高分的是银行客户经理。大马银行公会(ABM)、大马伊斯兰银行及金融机构协会(AIBIM)今日联合发布“2025年马来西亚零售银行业客户满意度调查”报告。这项由Kantar Malaysia独立执行的调研显示,我国银行业的整体客户满意度高达87%,净推荐值(NPS)则录得+43,反映出多数客户对现有的银行服务感到满意,并愿意向亲友推荐。该调查涵盖了19家传统商业银行与伊斯兰银...
Chinapress13 Mar, 2026 15:46pm - 2 months

(吉隆坡13日讯)市场调查显示,大马人对我国银行体系的满意度高达87%。据《2025大马零售银行业客户满意度调查》(Malaysian Retail Banking Industry Customer Satisfaction Survey 2025)结果显示,整体客户满意度达到87%,表明
Seehua13 Mar, 2026 15:33pm - 2 months

(吉隆坡13日讯)市场调查显示,大马人对我国银行体系的满意度高达87%。据《2025大马零售银行业客户满意度调查》(Ma...
Orientaldaily13 Mar, 2026 15:19pm - 2 months

“整体客户满意度达到87%,显示大多数客户对银行服务感到满意,而净推荐值为+43,反映客户愿意向家人和朋友推荐其银行。”...
Nanyang13 Mar, 2026 11:08am - 2 months

KUALA LUMPUR: Bursa Malaysia ditutup rendah hari ini apabila sentimen risiko merosot ketara susulan peningkatan semula konflik Amerika Syarikat (AS)-Iran, sekali gus mencetuskan jualan besar-besaran dalam pasaran ekuiti serantau.
BeritaHarian02 Mar, 2026 19:48pm - 2 months

KUALA LUMPUR: Bursa Malaysia ended broadly lower on Monday as risk sentiment deteriorated sharply following renewed escalation in the Middle East conflict, triggering a widespread regional equity sell-off.
NST02 Mar, 2026 19:02pm - 2 months

Shares of LEAP Market-listed Nova Pharma Solutions Bhd (KL:NPS), which is en route to being privatised by Southern Score Builders Bhd (KL:SSB8), will be suspended from trading on March 9.
TheEdge02 Mar, 2026 18:36pm - 2 months

Notable filings During the week of Jan 19 to 23, notable shareholding changes at Bursa Malaysia-listed companies included those at DXN Holdings Bhd (KL:DXN), where CGS International Securities Malaysia Sdn Bhd emerged as a substantial shareholder. According ...
TheEdge10 Feb, 2026 14:30pm - 3 months

聚宝建设(SSB8,0045,创业板)于周四(5日)举办投资者汇报会,向市场提供最新业务进展。...
Nanyang06 Feb, 2026 17:59pm - 3 months

KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
TheStar04 Feb, 2026 07:59am - 3 months

Southern Score Builders Bhd (KL:SSB8), whose bid to take over Nova Pharma Solutions (NPS) has already crossed the 90% regulatory threshold, said its stake in the LEAP Market-listed company increased further to 97.72% on Tuesday.
TheEdge03 Feb, 2026 20:21pm - 3 months

KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
TheStar26 Jan, 2026 08:18am - 3 months

(吉隆坡25日讯)聚宝建设(SSB8,0045,创业板建筑)宣布,针对Nova Pharma(NPS,03006,LEAP板医疗保健)的收购计划已突破90%门槛。聚宝建设已累计持有Nova Pharma的90.834%股份。根据马证交所报备文件,截至本月23日,聚宝建设已累计持有Nova Pharma的90.834%股份,因此可强制收购未持有股份,并将后者除牌下市。肯纳格投资银行代表聚宝建设发布声明指出,公司无意维持Nova Pharma在杰出企业家加速器平台(LEAP)的上市地位。...
Chinapress25 Jan, 2026 10:00am - 3 months

(吉隆坡23日讯)聚宝建设(SSB8,0045,创业板科技组)全面收购诺华医药(NPS,03006,LEAP市场医疗保健组)的计划,目前已经取得不少于90%股权,因此诺华医药将展开除牌行动。根据文告,截至1月23日,献购方已经取得诺华医药的90.83%股权,将要求诺华医药采取必要步骤以撤除上市地位。根据1月12日的献购文告,此献议将保持开放让股东接受,直至2月4日(周三)下午5时。聚宝建设是在2025年12月22日宣布以每股37仙价格,向诺华医药大股东收购4917万4000股股票,相当于3...
Sinchew23 Jan, 2026 20:42pm - 3 months

Southern Score Builders Bhd (KL:SSB8) said its bid to take over LEAP Market-listed Nova Pharma Solutions (NPS) has crossed the crucial 90% threshold a day after an independent adviser on the deal asked shareholders to accept it, calling it not fair but reasonable.
TheEdge23 Jan, 2026 19:31pm - 3 months

KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
TheStar23 Jan, 2026 07:59am - 3 months

(吉隆坡22日讯)聚宝建设(SSB8,0045,创业板建筑)上月出价每股37仙,拟全购杰出企业家加速器平台(LEAP)上市公司Nova Pharma(NPS,03006,LEAP板医疗保健);对此,后者独立顾问Mainstreet认为,有关献议“不公平”但“合理”,建议所有股东“接受献购”。Mainstreet指出,使用现金流折扣估值法(DCF)计算,Nova Pharma的合理价值应落在每股45.1仙,意味收购方的出价存在折价。“每股37仙的出价,比起该股的公允价值,折价8.1...
Chinapress22 Jan, 2026 17:17pm - 3 months

(吉隆坡22日讯)独立顾问认为,聚宝建设(SSB8,0045,创业板科技组)以每股37仙全面献购诺华医药(NPS,03006,LEAP市场医疗保健组)计划“不公平但合理”,建议股东接受献议。独立顾问MainStreet发布报告称,聚宝建设每股37仙全购价比诺华医药每股净资产14.4仙显著溢价22.6仙或156.94%,也较最后交易价23仙及首次公开售股(IPO)发售价20仙,显著溢价14仙或60.87%和17仙或85%。“不过,若根据贴现现金(DCF)估值方式计算,诺华医药价值达6726万令...
Sinchew22 Jan, 2026 14:22pm - 3 months